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ABSTRACT
Targeted mutagenesis directed by oligonucleotides
(ONs) is a promising method for manipulating the
genome in higher eukaryotes. In this study, we have
compared gene editing by different ONs on two new
target sequences, the eBFP and the rd1 mutant
photoreceptor bPDE cDNAs, which were integrated
as single copy transgenes at the same genomic site
in 293T cells. Interestingly, antisense ONs were
superior to sense ONs for one target only, showing
that target sequence can by itself impartstrand-bias in
gene editing. The most efficient ONs were short 25 nt
ONs with flanking locked nucleic acids (LNAs), a
chemistry that had only been tested for targeted
nucleotide mutagenesis in yeast, and 25 nt ONs with
phosphorothioate linkages. We showed that LNA-
modified ONs mediate dose-dependent target modi-
fication and analyzed the importance of LNA position
and content. Importantly, when using ONs with flank-
ing LNAs, targeted gene modification was stably
transmitted during cell division, which allowed reli-
able cloning of modified cells, a feature essential
for further applications in functional genomics
and gene therapy. Finally, we showed that ONs with
flanking LNAs aimed at correcting the rd1 stop muta-
tion could promote survival of photoreceptors in
retinas of rd1 mutant mice, suggesting that they are
also active in vivo.
INTRODUCTION
Targeted mutagenesis is a major method of genetics which, in
practice, still remains restricted to the mouse model organism
and a few specific cell lines in other higher eukaryotes (1).
Furthermore, it relies on homologous recombination between
the targeted gene and large DNA molecules requiring the
construction of complex plasmid, BAC or adeno-associated
viral vectors. Therefore, strategies using simpler vectors for
targeted mutagenesis, such as oligonucleotides (ONs) or small
DNA fragments, constitute attractive alternatives to manip-
ulate the genome for both experimental and therapeutic pur-
poses. ON-mediated targeted mutagenesis has been used to
correct point mutations in cultured cells and in animal models
of human disease (2–4). Several types of ONs have been
shown to be active, including small RNA/DNA ONs,
single-stranded and branched ONs (3–5). Triplex-forming
ONs have also been used to induce sequence-specific deletions
(6). However, the critical experimental parameters and the
mechanisms involved in these methods are not well known.
Indeed, the high mutagenesis rates originally reported when
using small RNA/DNA ONs could often not be reproduced on
different targets or on identical targets using seemingly ident-
ical experimental conditions (3,7,8). Some authors have sug-
gested that mutagenesis rates could have been overestimated
in some studies because of PCR artifacts (3,9). Differences in
the sequences targeted as well as in the assays used to measure
mutagenesis rates make it difficult to compare the activity of
the vectors described in the various studies.
In this study, we have compared the targeting efficiency of
several types of ONs previously shown to mediate targeted
mutagenesis on both episomal and integrated single copy
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chromosomal targets. ONs with flanking LNAs, which contain
a methylene bridge connecting the 20-oxygen of ribose with
the 40-carbon (10), had been previously shown to direct tar-
geted nucleotide modification in yeast (11), but their activity
had not been reported in higher eukaryotes so far. Here, we
show that short specific ONs with flanking LNAs induced the
desired mutation at the DNA level and, importantly, that modi-
fied cell clones could be isolated and grown for each of the
sequences targeted, the eBFP and the rd1 mutant photore-
ceptor cDNAs. As previously shown for phosphorothioate
ONs (C. Andrieu-Soler et al., manuscript submitted), specific
ONs with flanking LNAs could increase the number of
photoreceptors in vivo in the retina of rd1 mice (12). Taken
together, our results suggest that short ONs with flanking
LNAs can be powerful reagents for targeted mutagenesis in
cultured cells and in animal models of human disease.
MATERIALS AND METHODS
Oligonucleotides
ONs were synthesized and purified by high-pressure liquid
chromatography by Proligo (Paris, France) with the exception
of the branched-PS-eGFP ON, which was synthesized by
Eurogentech. ONs in distilled water were quantified by
absorbance at 260 nm.
Plasmids
The pFRT/lacZeo vector contains a FRT site and a LacZ–
Zeocin fusion gene (Invitrogen, Cergy Pontoise, France).
pOG44 vector (Invitrogen) constitutively expresses the Flp
recombinase (13). peBFP and peGFP* were constructed by
inserting eBFP cDNA and eGFP cDNA, respectively, without
the translation initiation codon into BamH1/Xho1 sites of the
pcDNA5/FRT/TO plasmid (Invitrogen). prd1-eGFP* and
pPDE-eGFP* were constructed by inserting a 153 bp fragment
containing bPDE sequence spanning the rd1 mutation or its
wild-type counterpart, respectively, in HindIII/BamH1 sites
of the peGFP* (inserting a shorter fragment of rd1 sequence
in peGFP* or the 153 bp fragment in a peGFP containing
the translation initiation codon led to background green
fluorescence).
Cells cultures and establishment of stable cell lines
All media, fetal bovine serum (FBS) and Penicillin–
Streptomycin were from Gibco BRL. 293T cells were main-
tained in DMEM supplemented with 5% FBS (optionally
supplemented with Zeocin or 50 mg/ml hygromycin). Follow-
ing electroporation of linearized pFRT/LacZeo plasmid, 293T
cell clones having integrated pFRT/LacZeo were selected on
Zeocin. The clones containing a single FRT site were identi-
fied by Southern blot analysis. One of these clones was then
co-transfected with pOG44 and peBFP. Clones that had integ-
rated the peBFP plasmid at the FRT site via Flp recombinase-
mediated DNA recombination were selected with hygromycin.
Southern blot analysis was used to confirm that these stable
clones contained a single copy of the eBFP cDNA. The same
protocol was used to obtain 293T cells with an integrated
single copy of the rd1/eGFP* fusion construction.
In vitro analysis of gene conversion by
episomal transfection
One day before transfection, 3 · 105 293T cells were plated
per well for a 4 cm2 12-well plate. For one well, 2.5 ml of Plus
Reagent (Invitrogen) were added to a mixture of 66 pmol of
ON and 0.5 mg of plasmid diluted in 62.5 ml of Opti-MEM 1.
After 15 min of incubation at room temperature, 2 ml of Lipo-
fectamine (Invitrogen) diluted in 62.5 ml of Opti-MEM 1 were
added. After 15 min of incubation at room temperature, the
mixture was added to the cells plated in 750 ml of appropriated
DMEM growth medium with 5% FBS without antibiotic.
After 3 h at 37C, 750 ml of DMEM growth medium with
15% FBS was added. The percentage of episomal eBFP con-
version induced by different ONs (see Figure 2) was quantified
by flow cytometry (see below) by dividing the percentage of
green fluorescent protein (GFP)-positive cells per the percent-
age of BFP-positive cells. Each experiment was repeated at
least three times.
In vitro analysis of gene conversion by ON transfection in
stable cell lines
Optimal percentage of conversion was obtained with Lipo-
fectamine 2000 using the following protocol. One day before
transfection, 2.2 · 105 293T cells were plated per well for a
2 cm2 24-well plate. For one well, 2.5 ml of Lipofectamine
2000 were diluted in 62.5 ml of Opti-MEM 1 medium (Gibco
BRL). After 5 min at room temperature, Lipofectamine 2000
solution was mixed to 132 pmol of ON pre-diluted in 62.5 ml of
Opti-MEM 1 and incubated for 20 min at room temperature.
The mixture was added to the cells plated in 375 ml of appro-
priated growth medium with 5% FBS without antibiotic. The
resulting ON concentration was therefore of 264 nM. After 1 h
at 37C, the medium was replaced by growth medium with 5%
FBS with hygromycin. The total number of green fluorescent
cells (that were not red fluorescent cells) contained in each
well was counted under a 10· objective on a DM-IRB fluor-
escence microscope (Leica, Rueil Malmaison, France) with a
mobile stage. The percentage of integrated eBFP conversion
induced by different ONs (see Figure 2) was quantified by
reporting this number by the total number of cells. In cells
containing rd1-GFP construct, conversion of the rd1 stop
codon mutation lead to the expression of GFP but fluorescence
levels were too low for visual counting. The percentage of
GFP-positive cells was therefore quantified by flow cytometry
(as described below). Each experiment was repeated at least
three times.
Flow cytometry
Transfected 293T cells were analyzed on an EPICS Altra flow
cytometer (Beckman Coulter). The 488 nm argon-ion laser
was run at 250 mW of power, and the second argon laser
was tuned to 325 nm UV and operated at 50 mW. The
green fluorescence was collected after a 525–25 nm band
pass filter. For analysis, the blue emission from HO342 was
filtered through a 424/44 band pass filter and a minimum of
10 000 events was collected in a gate of viable cells. Analysis
of the data was performed with expo32 MultiCOMP software
(Beckman Coulter). After cell sorting, green-positive cells
were seeded in a 96-well plate and clones were expanded
on DMEM growth medium with 5% FBS and 50 mg/ml
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hygromycin. One 96-well plate allowed growing between 4
and 10 clones of green cells when starting from cells trans-
fected with LNA-modified ONs (n = 6 plates), whereas no
clones could be expanded from cells transfected with
phosphorothioate-modified ONs (n = 6 plates). These data
suggest that fraction cell survival is 4–10% for LNA
ON-treated cells and <0.1% (1/600) for phosphorothioate-
treated cells.
DNA sequence analyses
Genomic DNA was extracted from expanded GFP-positive
clones by isopropanol precipitation following lysis by
proteinase K digestion. Corrected eBFP cDNA was
amplified by PCR using CMV-F (cytomegalovirus-F)
(50-CGCAAATGGGCGGTAGGCGTG-30) and BGH-R (50-
TAGAAGGCACAGTCGAGG-30) primers and sequenced
by MWG-Biotech (Germany).
Analysis of gene correction in rd1 mutant mice
C3H/HeN mice homozygous for the nonsense mutation
(amino acid position 347) in the bPDE gene (Janvier,
Le Genest, France) were used. Mice were maintained in
clear plastic cages and subjected to a standard light:dark
cycle for 12 h. Experiments were conducted in accordance
with the ARVO Statement for the Use of Animals in Ophthal-
mologic and Vision Research and the institutional guidelines
regarding animal experimentation in Ophthalmic and Vision
Research. At days PN4, 6 and 8, rd1 mice received saline
iontophoresis coupled to phosphate-buffered saline (PBS) or
ONs intravitreal injections (further details are reported else-
where, C. Andrieu-Soler et al., manuscript submitted). For
tissue harvest, mice were sacrificed by a lethal dose of pen-
tobarbital (Ceva Sante´ Animale, Libourne, France) injected
intraperitoneally. Eyes of PN28 untreated, PBS- or ON-treated
(six eyes for each condition) rd1 mice were enucleated,
quickly frozen in Tissue-Tek OCT-compound (Bayer Dia-
gnostics) and sectioned (10 mm). For each eye, five sections
that included optic nerve were stained with hematoxylin and
eosin. For each section, the number of nuclei in the outer
nuclear layer (ONL) was counted at 400 mm from each
edge of the optic nerve on a 400 mm length (n = 10 values
for each eye). Results were expressed as means – SD and
compared using the non-parametric Mann–Whitney test.
P < 0.05 was considered as significant.
RESULTS
eBFP cDNA as a target for sequence-specific mutation
Blue fluorescent coding sequence was originally obtained by
screening GFP mutants for altered fluorescence. It was found
to depart from GFP cDNA by only two point mutations, a C to
T substitution resulting in a Y66H change in the fluorophore
and a second substitution resulting in a Y145F change in a
region considered to have no role in fluorescence specificity
(14). We therefore tested whether ONs of eGFP sequence
spanning codon 66 could convert eBFP cDNA into a new
GFP cDNA (coined nGFP, Figure 1) leading to the expression
of a GFP in two contexts: episomal or integrated as a single
copy transgene in cultured cells. nGFP differs from eGFP at
Figure 1. Features of assay for measuring gene editing. (A) Sequence of eBFP
and eBFP converted into a new GFP (nGFP) coding Tyr66 and Phe145. eGFP
sequence is also indicated to show the difference from eBFP and nGFP at codon
145. (B) Schematic representation of ONs tested for targeted mutagenesis.
Nomenclature: as, antisense; s, sense; ds, double-stranded; PO, phosphodiester;
PS, six phosphorothioate linkages starting from 50 and 30 ends; asterisk, phos-
phorothioate linkage; L, LNA nucleotide; LNA, LNA nucleotide at 50 and 30
end position; 1x0-LNA, LNA nucleotide at 50 end only; 0x1-LNA, LNA at 30
end only; [1x1]-LNA, LNA nucleotides at internal nucleotide positions 5 and
20; U, three 20-O-methyl uracyl RNA base starting from 50 and 30 ends;
branched-PS-eGFP, ON with specific structure consisting of double-stranded
DNA with 50 single-stranded DNA tail coupled together by a baseless deox-
yribose branching monomer described as B7 ON in (5). 430-ds-eGFP: 1–430 bp
of eGFP sequence. Sequences were as follows: 25-eGFPas, 50-ACTGCAC-
GCCGTAGGTCAGGGTGGT-30; 25-eGFP-s, 50-ACCACCCTGACCTACG-
GCGTGCAGT-30; 45-eGFPas, 50-CGGCTGAAGCACTGCACGCCGTAGG-
TCAGGGTGGTCACGAGGGTG-30; 45-eGFPs, 50-CACCCTCGTGACCA-
CCCTGACCTACGGCGTGCAGTGCTTCAGCCG-30; 25-PDEas, 50-ACTT-
TCTGCTACGTAGGTTGGAAGG-30; 25-PDEs, 50-CCTTCCAACCTACG-
TAGCAGAAAGT-30.
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codon145, making it possible to distinguish bona fide conver-
sion from potential contamination by eGFP cDNA (Figure 1).
Importantly, in this model, stable transmission of the targeted
gene modification can be examined by selection and expansion
of green fluorescent cells.
As described in Figure 1, single-stranded ONs of sequence
identical to either sense or antisense strands of eGFP cDNA
were synthesized according to several structures previously
reported to direct sequence-specific gene modification: stand-
ard phosphodiester chemistry (25-PO-eGFPs, 25-PO-eGFPas
and 45-PO-eGFPas), which was shown to be active in some
reports (15), modified with phosphorothioate linkages between
the six bases starting from 50 and 30 ends (25-PS-eGFPs,
25-PS-eGFPas and 45-PS-eGFPas) (16), with 20Omethyl-
uracyl-RNA at the 3 positions from the 50 and 30 ends
(25-U-eGFPs, 25-U-eGFPas and 45-U-eGFPas) (17) or with
LNAs at the 50 and 30 ends (25-LNA-eGFPs, 25-LNA-eGFPas,
45-LNA-eGFPas). A branched ON, consisting of double-
stranded DNA with a 50 single-stranded DNA tail coupled
together by a baseless deoxyribose branching monomer, fol-
lowing upon the original design reported by Olsen et al. (5),
was also tested (branched-PS-eGFP) as well as a double-
stranded fragment, consisting in a PCR product of 430 bp
amplified from eGFP cDNA (18) (430-ds-eGFP).
Relative conversion of episomal eBFP sequence
As expected from previous studies, all the ONs encoding eGFP
described in Figure 1 allowed detecting green fluorescent cells
after being co-transfected with peBFP, whereas a control ON
encoding an unrelated sequence did not. We compared the
relative activities of the ONs to convert eBFP cDNA into
nGFP cDNA by measuring the percentage of green fluorescent
cells (converted cells) relative to the number of blue fluores-
cent cells (transfected cells) by flow cytometry 3 days after
transfection (Figure 2 and Table 1). Based on green-cell quan-
tification, only relative conversion rates were calculated but
this allows to compare the activity of different ONs. The most
efficient were the branched-PS-eGFP and 430-ds-eGFP
vectors, which allowed obtaining green fluorescence
among 74% of transfected cells. The less efficient were
25-U-eGFPas and 25-PO-eGFPas, which allowed detecting
only 0.4 and 4.9% green cells, respectively. All other antisense
ONs tested showed a roughly equivalent efficiency ranging
between 27 and 57%. It appeared that for 25 nt long ONs, the
phosphorothioate and LNA modifications tested provided a
7-fold improvement over standard phosphodiester chemistry.
In contrast, for 45 nt long ONs, the chemical modifications
tested did not significantly improve conversion efficiency. In
addition, short 25 nt ONs were superior to their longer 45 nt
counterparts. We also observed that, for a given chemistry,
both sense and antisense ONs mediated gene modification;
however, as frequently reported in other models (3), a higher
efficiency was observed with the antisense ONs.
Figure 2. Conversion of episomal eBFP to GFP. Representative dotplots of 293T cells 3 days after co-transfection with (A) pLacZ and 45-PS-eGFPas ON, (B) peBFP
and 25-PS-PDEas ON and (C) peBFP and 45-PS-eGFPas ON as detailed in Materials and Methods. The control ON, 25-PS-PDEas, was of sequence complementary
tobPDE. The control plasmid, pLacZ, was an expression vector forb-galactosidase. Blue fluorescent only cells are in the upper left quadrant (UL) and green and blue
fluorescent cells, corresponding to converted cells, in the upper right (UR).
Table 1. Relative percentage of episomal eBFP conversion
ON Percentage of episomal
eBFP conversion – SD
25-LNA-scr 0.06 – 0.05
25-U-eGFPas 0.4 – 0.1
25-LNA-eGFPs 1.3 – 0.4
25-PO-eGFPas 5 – 0.7
25-PS-eGFPs 14 – 2
45-PS-eGFPas 27 – 2
45-PO-eGFPas 29 – 4
25-PS-eGFPas 36 – 8
25-LNA-eGFPas 37 – 3
45-U-eGFPas 47 – 6
45-LNA-eGFPas 57 – 2
430-ds-eGFP 74 – 7
Branched-PS-eGFP 74 – 5
Episomal eBFP conversion frequency was calculated as the number of green and
blue fluorescent cells (UR) divided by the number of blue fluorescent cells (UL
plus UR), which were determined by flow cytometry at 3 days after transfection
in 293T cells of the indicated ONs. Transfection experiments were repeated
three times.
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Conversion of a single copy eBFP transgene
The same set of ONs was next tested for their ability to convert
integrated eBFP cDNA into nGFP cDNA in 293T cells. For
this purpose, we created cells containing a unique copy of
eBFP, as demonstrated by Southern blot analysis (data not
shown), by the application of Flp recombinase methodology
(13). Briefly, peBFP, containing an FRT site, was
co-transfected with a Flp recombinase expression vector
into 293T-FRT cells, containing a single copy FRT-target
site, and a cell clone containing appropriate single copy integ-
ration of eBFP at the FRT site was selected. In the resulting
293T-eBFP cell line, the number of green cells counted after
transfection of ONs is therefore expected to directly reflect the
number of target gene copies specifically mutated.
As shown in Figure 3, when 293T-eBFP cells were trans-
fected with a control ON of sequence unrelated to GFP, no
green fluorescent cell was detected 3 days after transfection. In
contrast, green fluorescent cells could be observed following
transfection with the 25-LNA-eGFPas ON. Table 2 shows the
rates of conversion obtained with the different ONs tested. The
branched-PS-eGFP, 25-PS-eGFPas and 25-LNA-eGFPas ONs
were the most efficient ONs with efficiencies between 0.4 and
2‰. The less efficient ONs were 25-PO-eGFPas and 25-U-
eGFPas, as in assays of episomal targets, together with,
surprising, 430-ds-eGFP, which had proven to be the most
efficient on episomal targets. Other ONs tested showed effi-
ciencies ranging between 0.13 and 0.2‰. It appeared that for
25 nt long ONs, similar to the results obtained on episomal
targets, the phosphorothioate and LNA modifications tested
provided a strong improvement over standard phosphodiester
chemistry (30- and 60-fold, respectively). In contrast, for
45 nt long ONs, the chemical modifications tested did not
appear to significantly improve efficiency. Once more, short
25 nt ONs were superior to their longer 45 nt counterparts.
Concerning ON length, we found in independent experiments
that the short 25 nt ONs with phosphorothioate and LNA
modifications were also superior to a 60 nt long ON end-
capped with six phosphorothioate linkages (data not
shown). For a given chemistry, both sense and antisense ONs
were active; however, as observed for episomal targets, a
higher efficiency of gene modification was observed with
the antisense ONs (15- and 30-fold higher for LNA and PS
chemistries, respectively).
DNA sequence analysis of chromosomal eBFP cDNA
converted to a GFP cDNA
To demonstrate that the green fluorescence observed resulted
from conversion of eBFP to GFP coding sequence, we ana-
lyzed DNA sequence of the transgene. Single 293T-eBFP cells
emitting green fluorescence after transfection by 25-LNA-
eGFPas ON were isolated by flow cytometry and expanded.
Confirmation of the conversion of eBFP to GFP conversion
came from DNA sequence analysis of amplified genomic
DNA. The analysis of four clones derived from single
293T-eBFP cells emitting green fluorescence demonstrated
the specific modification of the targeted base after transfection
with 25-LNA-eGFPas ON (Figure 4). No other difference
from eBFP sequence was found in the entire coding sequence
analyzed. In particular, codon TTC145 specific to eBFP in the
region having no role in fluorescence specificity (14) was still
present. This control finding excluded the possibility of any
cross-contamination by eGFP cDNA during the course of our
experiments.
In contrast, we were unable to expand colonies of green
fluorescent cells from 293T-eBFP cultures transfected with
Figure 3. Chromosomal eBFP conversion after transfection of 293T-eBFP
cells with control or 25-LNA-eGFPas ONs. GFP expression was detected
by fluorescence microscopy of 293T-eBFP cells 3 days after transfection with
control (A) or 25-LNA-eGFPas ONs (C). Brightfield microscopy of 293T-
eBFP cells transfected with control (B) or 25-LNA-eGFPas ONs (D). The
control ON used was 25-LNA-PDEas of sequence complementary to photo-
receptor cGMP-phosphodiesterase. BFP expression could be detected
by western blot of 293T-eBFP cells but not by standard fluorescence micro-
scopy due to its low fluorescence yield and strong photobleaching compared
with GFP (14).
Table 2. Rates of chromosomal eBFP conversion in 293T-eBFP cells
ON Rate of chromosomal eBFP
conversion – SD (·103)
25-LNAscr 0.007 – 0.003
25-U-eGFPas 0.02 – 0.01
430-ds-eGFP 0.04 – 0.01
25-PO-eGFPas 0.05 – 0.04
25-PS-eGFPs 0.06 – 0.005
25-LNA-eGFPs 0.13 – 0.06
45-U-eGFPas 0.16 – 0.04
45-LNA-eGFPas 0.17 – 0.03
45-PS-eGFPas 0.2 – 0.05
45-PO-eGFPas 0.2 – 0.08
Branched-PS-eGFP 0.4 – 0.08
25-PS-eGFPas 1.7 – 0.2
25-LNA-eGFPas 2 – 0.3
sequence.
Rates of chromosomal eBFP conversion were calculated as the number of green
fluorescent cells detected by fluorescence microscopy 3 days after transfection
of 293T-eBFP cells with the indicated ONs divided by the total number of cells.
Transfectionexperiments were repeated at least three times. Thecontrol ON, 25-
LNA-scr, was of identical chemistry as 25-LNA-eGFPas but with scrambled
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25-PS-eGFPas or the branched-PS-eGFP ONs, the other two
ONs showing the highest efficiency of integrated transgene
conversion at 3 days. Following cell sorting, we also attempted
to grow cultures of pools of green fluorescent cells in order to
avoid the stress due to growth of isolated cells, and we
observed that the ratio of green fluorescent cells steadily
decreased over passages in culture, suggesting that the
growth of green fluorescent cells was severely impaired by
25-PS-eGFPas and the branched-PS-eGFP ONs and therefore
precluded stable transmission of the gene modification.
Conversion of chromosomal eBFP sequence by ONs
with flanking LNAs
Since 25-LNA-eGFPas proved to be one of the most efficient
ONs tested in 293T cells and allowed to isolate and expand
clones of cells containing the desired sequence modification,
LNA chemistry was further investigated.
First, dose–response studies were performed. A clear dose–
response was obtained when transfecting gradually higher
doses of 25-LNA-eGFPas ON into 293T-eBFP cells
(Figure 5A). We also examined whether repeating transfec-
tions could increase the percentage of conversion. As can be
observed in Figure 5B, one, two and three transfections every
24 h led to a progressive increase in the number of converted
cells detected.
We next tested ONs of different content in LNA nucleotides
on integrated (Table 3) eBFP target. 25-LNA-eGFPas and
25-1x0LNA-eGFPas (containing one LNA at the 50 end posi-
tion and no LNA at 30 end position) were the most efficient
ONs. The 25-0x1LNA-eGFPas ON (containing no LNA at the
50 end position and one LNA at 30 end position) and the control
25-LNA-eGFP-scr ON were virtually inactive on integrated
targets, suggesting that the presence of an LNA at the 50 end
position is essential to allow detectable sequence-specific
modification. In addition, 25-2x2LNA-eGFPas and 25-
[1x1]LNA-eGFPas ONs resulted in a slightly lower efficiency
than 25-LNA-eGFPas, suggesting that increasing the number
of LNAs or inserting LNAs at internal rather flanking positions
does not significantly improve conversion efficiency. Increas-
ing the number of LNAs had previously been shown to reduce
gene editing in yeast (11).
Correction of chromosomal rd1 mutation by ONs
with flanking LNAs
We next chose to compare the ability of phosphorothioate and
LNA-modified ONs to correct a second unrelated sequence,
the rd1 stop mutation in the photoreceptor bPDE that is
responsible for retinal degeneration in the mouse rd1 mutant
(12). A fragment of the bPDE cDNA containing the rd1 stop
mutation was fused upstream of eGFP cDNA to produce a
chimeric rd1-eGFP* sequence target for correction by ONs.
Stable integration of the rd1-eGFP* sequence was performed
by Flp recombinase methodology into the same 293T-FRT cell
Figure 4. DNA sequence analysis of converted clones. Sequence of chromo-
somal eBFP target in GFP-positive clones of 293T-eBFP cells treated with 25-
LNA-eGFPas. The coding sequence was amplified by PCR from genomic DNA
and directly sequenced, which confirmed that the eBFP sequence had been
converted to nGFP. The asterisk indicates the position of the modified base. The
sequences shown, coding respectively Tyr66 and Phe145, were from the same
chromatogram.
Figure 5. Dose-dependent conversion of chromosomal eBFP by 25-LNA-
eGFPas ON. (A) Rates of GFP-positive cells in 293T-eBFP cells at 3 days
after transfection with indicated doses of 25-LNA-eGFPas ON. The amount of
DNA in the transfection mixture was kept constant by the addition of a control
LNA ON of unrelated sequence. (B) Rates of GFP-positive cells in 293T-eBFP
cells transfected 1, 2 or 3 times with 25-LNA-eGFPas ON (determined 3 days
after the last transfection). Results are expressed as means – SD, represented
as vertical bars, corresponding to triplicates from a single transfection
experiment.
Table 3. Rates of chromosomal eBFP conversion using different types of LNA-
modified ONs in 293T-eBFP cells
ON Rate of chromosomal eBFP
conversion – SD (·103)
25-LNA-scr 0.007 – 0.003
25-0x1LNA-eGFPas 0.05 – 0.03
25-[1x1]LNA-eGFPas 0.1 – 0.03
25-2x2LNA-eGFPas 0.7 – 0.2
25-LNA-eGFPas 2.2 – 0.3
25-1x0LNA-eGFPas 2.5 – 0.08
Rates of chromosomal eBFP conversion were calculated as the number of green
fluorescent cells detected by fluorescence microscopy 3 days after transfection
of 293T-eBFP cells with the indicated ONs divided by the total number of cells.
Transfection experiments were repeated three times. The control ON, 25-LNA-
scr, was of identical chemistry as 25-LNA-eGFPas but with scrambled
sequence.
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line as above and the rd1-eGFP* transgene was therefore
integrated at the same genomic site than the eBFP cDNA
previously studied.
In this model, correction of the rd1 mutation will result in
the appearance of eGFP fluorescence. Phosphorothioate and
LNA-modified ONs were designed to correct the rd1 mutation
to wild-type bPDE. For each chemistry, sense (25-LNA-PDEs
and 25-PS-PDEs) or antisense (25-LNA-PDEas and 25-PS-
PDEas) ONs were used to target the transcribed or
non-transcribed DNA strand, respectively. When 293T-rd1-
eGFP* cells were transfected with control ON of unrelated
sequence, no GFP-positive cells were detected at 3 days after
transfection. In contrast, GFP-positive cells were observed
following transfection with 25-LNA-PDEas ON (data not
shown). Rates of gene correction by the different ONs were
measured by flow cytometry and results are given in Table 4.
Phosphorothioate ONs exhibited slightly higher rd1 correction
rates than LNA ONs of the same sequence. Interestingly, even
though the rd1-eGFP* target was integrated in 293T-FRT cells
at the same genomic site than the eBFP cDNA, the antisense
and sense ONs mediated gene correction at roughly identical
levels (antisense being only 1.2- and 1.4-fold more efficient
than sense sequence for PS and LNA-modifications, respect-
ively). ONs with partial LNA modification were also tested.
LNA modification of either 50 or 30 end was sufficient for gene
editing activity; however, LNA modification at the 50 end
resulted in higher activity than at the 30 end.
Furthermore, as in studies of the eBFP target, clones were
expanded from individual green-positive cells isolated follow-
ing transfection with 25-LNA-PDEas, and gene correction was
demonstrated by sequence analysis (Figure 6). In contrast, no
clones could be expanded from 293T-rd1-eGFP* cells trans-
fected with 25-PS-PDEas ON.
Improved photoreceptor cell survival in rd1 mice
treated with specific ONs with flanking LNAs
Because the rd1 mutation could be corrected by single-
stranded ONs with flanking LNAs when integrated in the
genomic DNA of 293T cells, we investigated whether this
mutation could also be targeted in vivo in rd1 mice. Using
a technique that we developed for ON transfer into mouse
retina, we were recently able to detect a modest improvement
of photoreceptor survival in rd1 mice following transfer of
25-PS-PDEs ON, which was correlated with a low-level of
gene correction (C. Andrieu-Soler et al., manuscript submitted).
Therefore, LNA and phosphorothioate-modified ONs were
transfected in retina of rd1 mice at postnatal days 4, 6 and 8.
We then examined photoreceptor cells in the ONL on eye
sections at PN28, a late degenerative stage in rd1 mice (19).
While a single row of cells was observed at PN28 in the
ONL of untreated rd1 retina (Figure 7A), numerous areas
Table 4. Rates of chromosomal rd1-eGFP* correction to bPDE-eGFP*
ON Rate of chromosomal
rd1/eGFP* correction –
SD (·103)
25-1x0LNA-PDEas 3 – 0.6
25-LNA-PDEs 5 – 3
25-0x1LNA-PDEas 6 – 2
25-LNA-PDEas 7 – 4
25-PS-PDEs 13 – 6
25-PS-PDEas 16 – 5
repeated three times.
Rates of chromosomal rd1-eGFP* correction to bPDE-eGFP* were calculated
as the number of green fluorescent cells divided by the total number of cells,
which were determined by flow cytometry at 3 days after transfection of the
indicated bPDE ONs in 293T-rd1-eGFP* cells. Transfection experiments were
Figure 7. Eye sections of control and treated rd1 mice at PN28 and photo-
receptor cell numbers in the outer nuclear layer (ONL). Hematoxylin–eosin
stained sections of eyes of (A) untreated, (B) PBS-treated, (C) 25-PS-PDEas
ON-treated and (D) 25-LNA-PDEas ON-treated rd1 mice. A and B are repre-
sentative of the entire ONL of the corresponding retinas, whereas (C and D) are
selected are as showing markedly increased cell numbers in the ONL of
ON-treated rd1 mice. Scale bars: 100 mm. (E) Counting of cells in the ONL
showed a modest but significant overall increase of cells in 25-PS-PDEas or
25-LNA-PDEas ON-treated compared to PBS-treated eyes (P < 0.0001) or
untreated eyes (P < 0.0001) (asterisk). Results were expressed as means – SD,
SD, represented as vertical bars, and compared using the non-parametric
Mann–Whitney test.
Figure 6. DNA sequence analyses of corrected clones. (A) rd1 and wt-bPDE
sequences. (B) Sequence of chromosomal rd1-eGFP* target in a GFP-positive
clone of 293T-rd1-eGFP* cells treated 25-LNA-PDEas. The coding sequence
was amplified by PCR from genomic DNA and directly sequenced, which
confirmed that the rd1 sequence had been corrected into wt-bPDE. The asterisk
indicates the position of the modified base.
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containing three to four rows of cells were scattered over the
ONL of mice treated with 25-LNA-PDEas and 25-PS-PDEas
ONs (examples are shown in Figure 7C and 7D). Areas of
ONL showing no improvement of photoreceptor survival may
correspond to lower levels of ON transfection. In control
PBS-treated eyes, a thickening of ONL could be observed
which was small but present over the entire retina
(Figure 7B), a phenomenon which is consistently observed
upon PBS injection (20,21). In order to quantitate the effect
of ON transfection on photoreceptor survival, ONL cell num-
bers were counted in retinas from treated and untreated rd1
mice. In 25-PS-PDEas ON- and 25-LNA-PDEas ON-treated
retinas, there was a modest but significant increase in ONL cell
numbers when compared with PBS-treated retinas or to the
untreated retinas from rd1 mice (Figure 7D). Results of a
preliminary screen had previously suggested that 25-PDEas
ON was inactive; the difference with the present study could
be due to synthesis or purification defects in the previous
ON batches used. As a comparison, ONL cell numbers meas-
ured here in rd1 retinas treated with 25-PS-PDEas and
25-LNA-PDEas ONs were roughly equivalent to those
obtained previously with 25-PDEs ON (C. Andrieu-Soler
et al., manuscript submitted). These results suggest that ONs
with flanking LNAs could stimulate sequence-specific modi-
fication in vivo. However, in contrast to the results obtained
in cultured cells, there was no benefit of LNA over phosphoro-
thioate modifications in this in vivo assay, and the number of
photoreceptor cells remained insufficient to obtain clinical
improvement.
DISCUSSION
Testing activity of ONs on single copy model
target genes
In order to measure gene editing at the single cell level, we
have used assays depending on detecting GFP following tar-
geted modification of GFP mutant cDNAs consisting either of
eBFP or a fusion between rd1-bPDE and GFP cDNAs.
Because we applied Flp recombinase methodology, we
could easily obtain cell lines containing the transgenes
integrated as transcriptionally active single copies. As a con-
sequence, GFP-fluorescence indicates the successful modifica-
tion of the target gene and the number of GFP-positive cells
provides a measure of target gene modification. Indeed, we
could rigorously validate the assay by directly showing that in
GFP-positive cells, the desired gene modification had been
successfully introduced and stably propagated after transfec-
tion with sequence-specific ONs with flanking LNAs. An asset
of our experimental approach is that further use of Flp recom-
binase methodology will allow introducing different model
gene targets at identical genomic sites and it should therefore
be invaluable to analyze the importance of the target DNA
sequence in gene editing. It should also facilitate the charac-
terization of complex ONs, such as RNA/DNA ONs, whose
gene editing efficiency can vary from one synthesis to another
(3,22,23). The strategy we have used to test correction of the
rd1 mutation, relying on detecting correction of an inactive
GFP fusion cDNA, could be easily applied to test the possib-
ility of correcting other stop codons involved in human or
animal diseases.
Strand-bias in ON-mediated mutagenesis is
dependent on target sequence
Targeted gene modification by ONs takes place in two steps:
pairing to the target, which likely involves protein complexes
that usually take part in homologous recombination, and gene
modification per se, which may involve mismatch repair or
other mechanisms (3). For the eBFP sequence, we have found
here that targeting the transcribed strand was much more effi-
cient than targeting the non-transcribed strand (15- to 30-fold),
as reported in most studies (3). In contrast, for the rd1-eGFP*
sequence, there was no significant difference. The two targets
tested, eBFP and rd1-eGFP*, were integrated at the same
genomic site of 293T-FRT cells and transcribed from the
same CMV promoter. Therefore, our results indicate that
the target sequence may by itself determine a strand-bias in
targeting efficiency, perhaps as a result of different abilities to
reach and pair to their target. A similar conclusion was
recently proposed following studies of an episomal target
(24). Such a conclusion does not exclude; however, that
genomic context (for example, determining orientation and
timing of replication) or the promoter of the target sequence
play an additional role in strand-bias. Until the molecular
mechanisms of gene editing by ONs are better understood,
it therefore remains important to test the activity of the two
complementary sequences in order to achieve the best effici-
ency of gene editing.
Properties of the ON vectors
Using our assays of episomal and integrated eBFP targets, we
have compared the activity of several types of single-stranded
ONs as well as a branched ON and a double-stranded frag-
ment. It appeared that short single-stranded ONs with flanking
LNAs were efficient vectors, allowing gene editing of 0.2%
integrated eBFP target sequences. Importantly, similar effi-
ciencies were observed for the second target tested here,
the rd1 stop mutation, as well as for a third unrelated sequence
(C. Andrieu-Soler et al., manuscript in preparation), suggesting
that short ONs with flanking LNAs constitute a simple and
robust ON design for gene editing.
When comparing single-stranded vectors targeting the
eBFP sequence, several observations could be made. First,
we found that 25 nt ONs end-capped with single LNAs or
with six phosphorothioate linkages were 30- to 60-fold more
efficient than their non-modified counterparts, most likely due
to increased resistance to nucleases and as a consequence a
higher concentration of effective ON reaching the nucleus
after transfection. Second, we also found that 25 nt ONs
end-capped with single LNAs or with six phosphorothioate
linkages were consistently superior to their longer counter-
parts. Shorter ONs may mediate more efficient gene editing
per se, for instance as a result of higher affinity to proteins
facilitating recognition or invasion of the target double-
stranded sequence. Longer ONs may also be more prone to
binding to non-specific sites, thereby diluting effective ON
concentration at the targeted sequence. Third, we found that
chemically modified ONs of 45 nt were not superior to the ON
of standard chemistry. This observation was unexpected and
may perhaps be explained by the ability of the 45 nt sequence
to adopt structures conferring resistance to nucleases. In any
case, we must be cautious in interpreting differences between
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ON activities. Many steps are necessary to achieve gene
editing: transfection, nucleocytoplasmic transport, binding
to molecular machines responsible for DNA editing, annealing
to target DNA, degradation by nucleases . . . , all of which may
be differentially affected by ON chemistry and sequence and
impact on final ON activity.
Surprisingly, the 430-ds-eGFP exhibited limited activity
on integrated targets even though it was relatively efficient
on episomal eBFP cDNA. We tested extensive transfection
conditions but no increase in conversion of chromosomal
eBFP could be observed (data not shown). Differences in
transfection conditions may be involved but are unlikely to
entirely explain the very low activity of 430-ds-eGFP on
integrated targets. In our model, the sequence homologous
to 430-ds-eGFP starts immediately downstream of the
CMV transcription initiation site. In consequence, association
of 430-ds-eGFP to its homologous sequence or recruitment of
the recombination machinery may be limited by the transcrip-
tion initiation complex. Considering the high efficiency of
small homologous fragments reported in other studies (18),
our finding suggests that this method is extremely target-
dependent. It nevertheless deserves further investigation,
because it may allow performing more extensive mutations
than with shorter ONs.
We have also found that a branched ON was roughly equi-
valent to the best single-stranded vectors on both episomal and
chromosomal targets. This is the second example of gene
targeting with branched ONs, which were originally designed
by Olsen et al. (5), and it therefore proves to be an efficient
vector. The branched ON structure is reminiscent of results
obtained by Parekh-Olmedo et al. (11), who showed that in
yeast, a hybrid between a long ON and a shorter complement-
ary ON could exhibit higher activity than either ON taken
alone. However, in our hands, such hybrids did not signific-
antly change gene editing levels, whether annealing of
ONs was performed prior to transfection or not (data not
shown).
Stable transmission of targeted gene modification by
ONs with flanking LNAs
LNAs are proving to be versatile reagents in many aspects of
gene control and manipulation (10). Insertion of LNAs into an
ON was originally designed to increase binding affinity toward
complementary DNA and RNA. LNAs are therefore important
tools in diagnostic and analytical applications involving nuc-
leic acid hybridization. Additional important benefits were
found in LNAs, including resistance to nucleases (25,26).
In our study, an ON with a single LNA at its 50 end only
was as efficient as an ON flanked by LNA at both ends on
the eBFP sequence target and an ON with a single LNA at its 30
end only was as efficient as an ON flanked by LNA at both
ends on the second rd1-eGFP sequence target. Therefore, a
single protection may be sufficient but no general rule can be
made: the differences observed between ONs with a single
LNA at either 50 or 30 end are gene dependent. LNA modi-
fication at both ON ends therefore appears to be the optimal
chemistry to use for gene editing. A second important feature
of ONs incorporating LNAs is their low toxicity in vivo
(25,26). The latter property likely explains why LNA-
modified ONs were superior to the branched and
PS-modified ONs in making it possible to isolate clones of
cells bearing the desired sequence-specific modification.
Branched ONs have been previously shown to be cytotoxic
(5), apoptosis being triggered in corrected cells. Cytotoxicity
is also a well-known caveat of phosphorothioate ONs that
likely explains why growth of corrected cells appeared
severely impaired. Other studies of gene editing by
phosphorothioate-modified ONs have either described normal
growth of corrected cells (16) or impaired cell cycle progres-
sion (27). Cytotoxicity of phosphorothioate-modified ONs is
known to be sequence-dependent (28) and this could explain
such variability in the growth of corrected cells. Other experi-
mental differences may also be involved, such as cell lines and
ON transfection reagents used. Variable success has similarly
been reported for RNA/DNA ONs, which either did (29) or did
not (30) allow growth and isolation of corrected cells. Pos-
sibly, further studies of such ONs may allow reducing their
cytotoxicity without compromising their ability to mediate
gene modification. However, in contrast, the use of 25 nt
ONs with flanking LNAs appears to provide a straightforward
and robust design for obtaining cell lines containing stable
transmission of the desired gene modification. In addition
to the two targets described here, we have recently obtained
293T cell lines with modification of several other model
sequences, further validating the power of ONs with flanking
LNAs. The next step will hence consist in demonstrating tar-
geting of endogenous genes. The mutagenesis rates measured
here, in the range of 0.1–0.5%, appear too low to envisage
direct isolation of modified cells. Progressive isolation from
pools of treated cells by PCR (15) or the use of a selection
strategy, as suggested by Yoon and co-workers (31), will
therefore be necessary to obtain cells with targeted mutations
in endogenous genes. Mutagenesis rates may also be increased
as a result of better understanding of the mechanisms of gene
editing directed by ONs (32) or by the simultaneous use of
triplex-forming ONs (6).
Finally, we compared the activity of LNA- and
phosphorothioate-containing ONs in the rd1 mouse model.
Following transfer of ONs into the retina of rd1 mouse mutant,
an ON with flanking LNAs led to a modest but significant
increase in photoreceptor survival, which was slightly lower
than that obtained with phosphorothioate ONs. This result is
consistent with the finding that the ON with flanking LNAs
was less active on the single copy rd1-eGFP* transgene than
the phosphorothioate ON at 3 days after transfection. Given
that photoreceptor cells stop dividing after postnatal day 6, i.e.
during the period when ON treatments were performed in rd1
mice, it may not be so surprising that the differences observed
on growth of cultured cells in vitro do not translate into a
detectable advantage when treating rd1 photoreceptor cells.
One may expect to observe an advantage of LNA- over
phosphorothioate-modified ONs in treatment of diseases
involving proliferating cells or when correction rates achieved
lead to therapeutic benefit and differences in toxicity between
the two chemistries then become relevant. The comparison we
have performed of targeted mutagenesis directed by LNA- or
phosphorothioate-modified ONs on different targets illustrates
the need to carefully tailor ON design to the specific gene
target and experimental purpose. Our finding that ONs with
flanking LNAs allow to reliably isolate cell lines containing
the desired gene modifications may help in further applications
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of ON-mediated targeted mutagenesis in functional genomics
and gene therapy.
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